NANOMOL TECH
Desconocido
CLIMB: Complex lipid membranes for science and technology
NANOMOL TECHNOLOGIES SL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2023-DN-01
CLIMB-Complex lipid membranes for science and technology is a doctoral network of leading European lipid-research laboratories with highly c...
2024-06-25 - 2029-01-31 | Financiado
2024-06-25 - 2029-01-31 | Financiado
ARISTOS: ARISTOS Postdoctoral Program in Biomedicine and Health Sciences
NANOMOL TECHNOLOGIES SL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-COFUND-01
ARISTOS aims to be the next Postdoctoral Program in Biomedicine and Health Sciences cofunded by the Horizon Europe Marie Skłodowska-Curie CO...
2022-12-05 - 2028-05-31 | Financiado
2022-12-05 - 2028-05-31 | Financiado
NABIHEAL: ANTIMICROBIAL NANOSTRUCTURED BIOMATERIALS FOR COMPLEX WOUND HEALING
NANOMOL TECHNOLOGIES SL
participó en un
HORIZON EUROPE:
HORIZON-CL4-2022-RESILIENCE-01
Complex wounds impact the quality of life of more than 2% of total population in developed countries being a global health problem with sign...
2022-11-29 - 2026-12-31 | Financiado
2022-11-29 - 2026-12-31 | Financiado
DOCFAM-PLUS: DOCtoral training programme in Functional Advanced Materials Towards a Better Future
NANOMOL TECHNOLOGIES SL
participó en un
HORIZON EUROPE:
HORIZON-MSCA-2021-COFUND-01
DOCFAM+ (DOCtoral training programme in Functional Advanced Materials: Towards a Better Future) is a new excellent doctoral programme for th...
2022-10-11 - 2028-02-29 | Financiado
2022-10-11 - 2028-02-29 | Financiado
Phoenix: Pharmaceutical Open Innovation Test Bed for Enabling Nano pharmaceutical Innovative Products
NANOMOL TECHNOLOGIES SL
participó en un
H2020:
H2020-NMBP-TO-IND-2018-2020
Nano-pharmaceuticals have the potential to drive the scientific and technological uplift, offering great clinical and socio-economic benefit...
2020-12-16 - 2025-02-28 | Financiado
2020-12-16 - 2025-02-28 | Financiado
Micro4Nano: Multifunctional nanocarriers for nonlinear microscopy new tools for biology and medicine
NANOMOL TECHNOLOGIES SL
participó en un
H2020:
H2020-MSCA-RISE-2020
The direct 3D visualization of large sections of biological tissues, made possible by multiphoton microscopy, has the potential to revolutio...
2020-11-05 - 2026-09-30 | Financiado
2020-11-05 - 2026-09-30 | Financiado
Nano-OligoMed: Hybrid Nanostructured Oligonucleotide Platforms for Biomedical Applications
NANOMOL TECHNOLOGIES SL
participó en un
H2020:
H2020-MSCA-RISE-2017
Nanotechnology has received widespread attention in the last several decades due to the technological breakthroughs it has enabled across se...
2017-11-09 - 2022-11-30 | Financiado
2017-11-09 - 2022-11-30 | Financiado
Smart-4-Fabry: Smart multifunctional GLA nanoformulation for Fabry disease
NANOMOL TECHNOLOGIES SL
participó en un
H2020:
H2020-NMBP-2016-2017
Lysosomal storage disorders (LSD) diseases are a group of rare diseases that currently lack a definitive cure. LSD incidence is about 1:5,00...
2016-11-22 - 2020-12-31 | Financiado
2016-11-22 - 2020-12-31 | Financiado
Nano2Fun: Nanochemistry of molecular materials for 2 photon functional applications
NANOMOL TECHNOLOGIES SL
participó en un
FP7:
Nano2Fun's main target is the education of a new generation of scientists with a solid multidisciplinary scientific background, a good attit...
Financiado
Financiado
THERAGLIO: Microbubble driven multimodal imaging and theranostics for gliomas
NANOMOL TECHNOLOGIES SL
participó en un
FP7:
Microbubbles (MBs) are used as contrast agent in ultrasound (US) imaging for a variety of tumours while little has been done for glioblastom...
Financiado
Financiado
* No se disponen de datos de la empresa actual.